Segment Results (Additional Selected Financial Information For Reportable Segments) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Segment Reporting Information [Line Items]
Depreciation expense	$ 15,700	$ 14,700
Amortization expense	58,861	47,400
Branded Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Depreciation expense	4,037	6,305
Amortization expense	20,723	21,280
Generic Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Depreciation expense	7,569	3,170
Amortization expense	18,614	10,881
Devices [Member]
Segment Reporting Information [Line Items]
Depreciation expense	2,086	2,802
Amortization expense	15,524	15,239
International Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Depreciation expense	141	0
Amortization expense	4,000	0
Corporate Unallocated [Member]
Segment Reporting Information [Line Items]
Depreciation expense	$ 1,894	$ 2,465